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Introduction
Medication overuse headache (MOH) implies secondary
headache on a daily or near daily basis, for 15 days or
more a month for 3 month and chronic migraine CM is
the most common subtypes of MOH in speciality care
[1]. Flunarizine and topiramate are considered as first-
choice drugs in prophylactic treatment of episodic or
transformed migraine(2). Topiramate is considered as
first-choice drug in treatment of CM (3).
Objetives
We analyze two independent case-series with (CM) and
(MOH) according to ICHD-II criteria treated with topir-
amate or flunarizine as first intention and compare the
results.
Methods
Patients were medication over users and naïve to (oral)
prophylactic therapy. In both groups, the main effective-
ness variables (reduction in the number of seizures and
days with headache at four months of treatment and
responder rates) were analysed.
Results
The study included 348 patients: 188 with flunarizine
(88.2% females; mean age: 43.8 ± 13.6) and 160 with
topiramate (88.0% females; mean age: 40.2 ± 13.2). No
significant differences were found between groups as
regards mean age, sex and number of migraines and
days with headache in the previous month. There was a
significant decrease (0.0001) in the mean number of
crisis in the fourth month of treatment, but with no sig-
nificant difference between them: topiramate (9.3 ± 7.1
to 4.6 ± 6.1) and flunarizine (9.9 ± 7.3 to 4.1 ± 5.0).
Mean of days with headaches at four month of treat-
ment, topiramate 9.7±8.5, flunarizine 6.9±8.4 (.0106);
the respondent rate was: topiramate 57.9%, flunarizine
72.6% ( .0391). The mean reduction in the number of
days with headaches: topiramate 48.2%, flunarizine
63.3% (.0040).
Conclusions
Both drugs showed effectiveness when used as the pre-
ferred drug in the preventive treatment of (CM) and
(HOM). Flunarizine offered better results on reduction
in the number of days with headaches and minor side
effects than topiramate.
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